GenAI models demonstrate high accuracy and consistency in pathological grading and risk assessment for lung adenocarcinoma.
Key Details
- 1Study tested GPT-4o, Claude-3.5-Sonnet, and Gemini-1.5-Pro on 492 digitized slides from public and independent sources.
- 2Claude-3.5-Sonnet achieved 82.3% accuracy in lung adenocarcinoma grading, with strong repeatability.
- 3Models extracted 11 histological features and 4 clinical variables for comprehensive risk assessment.
- 4Diagnostic and prognostic tasks were completed in minutes, much faster than human experts.
- 5AI models reduced inter-observer variability and enabled objective, standardized analysis across multiple samples.
- 6GenAI models surfaced new significant prognostic factors including interstitial fibrosis and papillary patterns.
Why It Matters
This breakthrough underscores the transformative potential of generative AI in digital pathology, promising faster, standardized, and potentially more insightful cancer diagnosis and prognosis translation. Such advances could boost accuracy in resource-limited settings and improve reproducibility in pathological assessments, reshaping clinical workflows.
Source
EurekAlert
Related News
•EurekAlert
AI-Assisted Tracking Reveals Stem Cell Therapy Promotes Stroke Recovery in Mice
Mice with ischemic stroke receiving human neural stem cell transplants showed robust brain recovery, measured using AI-based limb tracking.
•EurekAlert
Moffitt Develops AI Model to Predict Urgent Care in Lung Cancer Patients
Moffitt Cancer Center researchers created machine learning models that use patient-reported outcomes and wearable data to predict urgent care visits for non-small cell lung cancer patients.
•EurekAlert
AI Predicts Keratoconus Progression Using OCT Scans
Researchers have developed an AI model that accurately predicts which keratoconus patients require treatment by analyzing OCT eye scans and clinical data.